From the Research
Ivermectin is not recommended for treating prostate cancer as there is no established dosing regimen or FDA approval for this use. The most recent and highest quality study, 1, suggests that ivermectin may have antitumor effects in preclinical studies, but its use in prostate cancer treatment is still largely experimental and not supported by clinical evidence.
Current Standard Treatments
Currently, standard prostate cancer treatments include:
- Surgery
- Radiation therapy
- Hormone therapy
- Chemotherapy
- Immunotherapy
These established treatments have undergone rigorous clinical trials demonstrating their efficacy and safety profiles, as discussed in studies such as 2, 3, 4, and 5.
Risks of Unproven Treatments
Using unproven treatments like ivermectin could delay effective treatment and potentially cause harm through side effects or drug interactions. Any investigation of ivermectin for cancer treatment should occur only within properly designed clinical trials under medical supervision.
Patient Guidance
Patients with prostate cancer should work with their oncologists to develop appropriate treatment plans using evidence-based therapies. This approach ensures the best possible outcomes in terms of morbidity, mortality, and quality of life, as emphasized by the consensus recommendations from the US Prostate Cancer Conference 2024, 3.